Skip to content

Neuroplasticity: all studies

Page 109 of 178: studies 1,081 to 1,090 of 1,772, newest first. Back to the neuroplasticity overview

Research

PENGARUH DZIKIR TERHADAP NEUROPLASTISITAS OTAK: PERSPEKTIF AL-QUR’AN DALAM MENINGKATKAN KESEHATAN MENTAL

Madinah: Jurnal Studi Islam March 23, 2025 Rifqatul Husna, Arina Isa Salsabila, Salih Abdulrahman Alsounusi

In this modern era, mental health is an important aspect of human life that is often overlooked. The practice of dhikr, as a form of Islamic meditation, has been recognized in the Islamic tradition as a way to get closer to Allah and calm the soul. This study aims to identify the effect of dhikr on brain neuroplasticity and its implications for mental health. Using the thematic tafsir method,...

Exploring novel therapeutic strategies: Could psychedelic perspectives offer promising solutions for Alzheimer's disease comorbidities?

Dialogues in Clinical Neuroscience March 19, 2025 Michael Davidson, Gabriela-Dumitrita Stanciu, Jonathan Rabinowitz et al. 2 citations

The increasing prevalence of dementia within an ageing global population, combined with prolonged life expectancy, accentuates Alzheimer's disease (AD) as a multifaceted healthcare challenge. This challenge is further compounded by the limited therapeutic options currently available. Addressing the intricacies of AD management, the mitigation of comorbidities has emerged as a pivotal facet of...

DOI: 10.1080/19585969.2025.2480566 (opens in new tab) Full text (opens in new tab) Psychedelics Mental health Alzheimer's disease Brain research

Ketamine as adjuvant treatment in eating disorders: an exploratory study of a case series and retrospective analysis.

Journal of Eating Disorders March 17, 2025 Paula J Escobedo-Aedo, Chris Serrand, Sarah Kabani et al. 4 citations

Eating disorders (EDs) significantly impair physical health and psychosocial functioning. Few effective therapeutic approaches exist for EDs, particularly in Anorexia Nervosa (AN). The use of ketamine, already characterized as a noncompetitive NMDA antagonist anesthetic in depression and suicidal ideations, could be an innovative adjuvant treatment for the AN spectrum. We describe a case series...

DOI: 10.1186/s40337-025-01232-y (opens in new tab) Full text (opens in new tab) Ketamine therapy Eating disorder treatment Mental health research Anorexia treatment +5

PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERS

Journal of medical & health sciences review. March 11, 2025 Ahmad Daryani, Muhammad Ali, Usman Ul Haq

Psilocybin, MDMA, and LSD have recently emerged as popular psychedelic substances for use in psychopharmacology in managing various disorders including treatment-resistant depression, PTSD, and anxiety. These substances mainly affect the serotonergic receptors that involve the regulation of consciousness, perceptions, and cognition. These unique alterations in brain connectome show the...

Breaking the cycle: a systematic review of neurobiological mechanisms and psychotherapeutic innovations in ketamine addiction.

Journal of Addictive Diseases March 6, 2025 Christopher Lomas 2 citations

This systematic review synthesizes current evidence on non-prescribed ketamine use, emphasizing its neurobiological impacts and psychotherapeutic interventions. Patterns of misuse demonstrate the complex interplay of neurobiological, socio-economic, demographic and psychological factors with adolescents, women and polysubstance users identified as high-risk groups. Neurobiological findings...

Ayahuasca Mitigates Morphological Cortical Alterations in Juvenile Non-human Primates Following Chronic Stress Exposure

Research Square March 5, 2025 Expedito Do Nascimento Júnior, Luiz Pereira, Wigínio Lira-Bandeira et al. preprint

Abstract Depression remains a debilitating mental health disorder affecting millions worldwide, with growing prevalence among adolescents. Recent studies highlight the critical role of the somatosensory cortex in the neuropathology of depression, including structural alterations that impair cortical function. This study investigates the prophylactic effects of ayahuasca, a traditional...

Serum BDNF Increase After 9-Month Contemplative Mental Training Is Associated With Decreased Cortisol Secretion and Increased Dentate Gyrus Volume: Evidence From a Randomized Clinical Trial.

Biological Psychiatry Global Open Science March 1, 2025 Lara M.c. Puhlmann, Pascal Vrtička, Roman Linz et al.

In this study, we investigated whether mindfulness- and meditation-based mental training that improves stress regulation can upregulate BDNF (brain-derived neurotrophic factor), an important promoter of hippocampal neuroplasticity, and examined cortisol reduction as a mediating pathway. In a randomized clinical trial, 332 healthy adults were randomly assigned to one of the 3 training cohorts or...

Effects of ketamine on GABAergic and glutamatergic activity in the mPFC: biphasic recruitment of GABA function in antidepressant-like responses.

Neuropsychopharmacology March 1, 2025 Manoela V. Fogaça, Fernanda Daher, Marina R. Picciotto 22 citations

Major depressive disorder (MDD) is associated with disruptions in glutamatergic and GABAergic activity in the medial prefrontal cortex (mPFC), leading to altered synaptic formation and function. Low doses of ketamine rapidly rescue these deficits, inducing fast and sustained antidepressant effects. While it is suggested that ketamine produces a rapid glutamatergic enhancement in the mPFC, the...

Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons

Journal of Neurochemistry February 28, 2025 Aneta Petrušková, Debarpan Guhathakurta, Enes Yağız Akdaş et al. 8 citations

ABSTRACT The serotonergic psychedelics psilocybin, LSD and DMT hold great promise for the development of new treatments for psychiatric conditions such as major depressive disorder, addiction and end‐of‐life anxiety. Previous studies in both animals and humans have confirmed the effects of these drugs on neuronal activity and plasticity. However, the understanding of the mechanisms of action of...

Psychedelics as an alternative to traditional pharmacotherapy in treating mental disorders – a review of latest studies

Medical Science February 25, 2025 Jakub Pudźwa, Kamil Gibczyński, Karol Leśniewski et al.

Objective: The purpose of the following review was to summarize the recent studies on proposed mechanisms of action of psychedelic drugs (psilocybin, MDMA, LSD), their therapeutic potential in mental disorders (depression, PTSD, addictions), and the evaluation of their safety. This review also discusses the barriers to the clinical implementation of these agents. Methodology: The paper combines...